Covered recipient · General Payments record
JOHN C ARAUJO
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$33,366.71
- Reported across 84 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $408.63 | 34 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $403.42 | 31 |
| Janssen Biotech, Inc. | $67.69 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.45 | 1 |
| Sumitomo Pharma America, Inc. | $16.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $20.45 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086248142 | CMS |
| Exelixis Inc. | $16.82 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559422 | CMS |
| Exelixis Inc. | $13.54 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559420 | CMS |
| Exelixis Inc. | $2.49 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559424 | CMS |
| Exelixis Inc. | $21.97 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559434 | CMS |
| Exelixis Inc. | $22.45 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559430 | CMS |
| Exelixis Inc. | $0.85 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559432 | CMS |
| Exelixis Inc. | $0.30 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559428 | CMS |
| Exelixis Inc. | $24.41 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559426 | CMS |
| Exelixis Inc. | $22.48 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559478 | CMS |
| Exelixis Inc. | $23.71 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559436 | CMS |
| Exelixis Inc. | $2.00 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559438 | CMS |
| Exelixis Inc. | $22.20 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559476 | CMS |
| Exelixis Inc. | $1.14 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559468 | CMS |
| Exelixis Inc. | $10.27 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559470 | CMS |
| Exelixis Inc. | $9.10 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559460 | CMS |
| Exelixis Inc. | $7.17 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559464 | CMS |
| Exelixis Inc. | $3.15 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559466 | CMS |
| Exelixis Inc. | $3.36 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559474 | CMS |
| Exelixis Inc. | $22.45 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559462 | CMS |
| Exelixis Inc. | $1.67 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559472 | CMS |
| Exelixis Inc. | $6.02 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559450 | CMS |
| Exelixis Inc. | $18.75 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559452 | CMS |
| Exelixis Inc. | $12.03 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559448 | CMS |
| Exelixis Inc. | $1.51 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559440 | CMS |
| Exelixis Inc. | $0.27 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559442 | CMS |
| Exelixis Inc. | $2.21 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559444 | CMS |
| Exelixis Inc. | $0.27 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559446 | CMS |
| Exelixis Inc. | $8.66 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559454 | CMS |
| Exelixis Inc. | $99.00 | 11/12/2024 | Education | Undisputed | 01/23/2026 | 1138559418 | CMS |
| Exelixis Inc. | $8.96 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559456 | CMS |
| Exelixis Inc. | $14.21 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138559458 | CMS |
| Janssen Biotech, Inc. | $33.42 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078730176 | CMS |
| Janssen Biotech, Inc. | $34.27 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078725155 | CMS |
| Sumitomo Pharma America, Inc. | $16.07 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148822074 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.